Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: Two-year results - VIP report #4.

被引：0

作者：

Lim, JI ^{[1
]}

机构：

[1] Univ So Calif, Doheny Eye Inst, VIP Study Grp, Los Angeles, CA USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2001年 / 42卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1637

引用

页码：S304 / S304

页数：1

共 50 条

[31] Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review (vol 18, pg 955, 2008)
Costagliola, C.
Campa, C.
Incorvala, C.
Parmeggiani, F.
Menzione, M.
Della Corte, M.
Rinaldi, M.
Romano, M.
Semeraro, F.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (02) : 329 - 329
[32] Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy
Noémi Maár
Erdem Ergun
Alexandra Luksch
Michael Stur
Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244
[33] Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
Ergun, E
Heinzl, H
Stur, W
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (03) : 434 - 438
[34] Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy
Maar, Noemi
Ergun, Erdem
Luksch, Alexandra
Stur, Michael
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 244 (10) : 1262 - 1266
[35] Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up
Lam, DSC
Chan, WM
Liu, DTL
Fan, DSP
Lai, WW
Chong, KKL
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (10) : 1315 - 1319
[36] Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: One-year results
Gupta, R
Browning, AC
Wu, K
Sokal, M
Amoaku, WM
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (03) : 561 - 562
[37] Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration using verteporfin (Visudyne): Two year results of 2 randomized clinical trials - TAP report #5
Bressler, SB
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S532 - S532
[38] Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia
Srivastava, SK
Sternberg, P
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (05): : 669 - 671
[39] A Long-Term Study of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization at the Edge of Chorioretinal Atrophy in Pathologic Myopia
Pece, Alfredo
Milani, Paolo
Isola, Vincenzo
Pierro, Luisa
OPHTHALMOLOGICA, 2011, 225 (03) : 161 - 168
[40] Five-year results of verteporfin photodynamic therapy in pathologic myopia: Third year of an open-label extension of the VIP Trial
Soubrane, G
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904

← 1 2 3 4 5 →